NEW YORK (GenomeWeb News) – Partners in Denmark have joined to embark on a €5.2 million ($6.8 million) personalized cancer diagnostic project.
The project aims to develop a platform for precision medicine using gene expression analysis so that individual cancer patients can receive treatments that have been tailored specifically for them.
The members of the project are Vejle Hospital, the Technical University of Denmark, Exiqon, and Intomics. The five-year project will focus on colorectal cancer, and the Danish National Advanced Technology Foundation has provided €3.0 million toward it.
The hospital has conducted research into colorectal cancer, it said, and will contribute research with "well-defined patient groups." Exiqon will provide its expertise in and technology for measuring genetic biomarkers, while Intomics and the university provides their bioinformatics expertise in handling large amounts of complex genetic data.